The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on September 28, 2026

15 hours ago

Kiteworks' Decision to Ensure Customer Data Protection Through Customer-Wide Shutdown Navigates Credible Threat

Indeterminate EIN Presswire

17 hours ago

Aspire Rejuvenation's Tomo Marjanovic Holds International Hormone Therapy Credential

Indeterminate EIN Presswire

17 hours ago

70-Year-Old Lalit Kumar Takes Natural Spices Online, Reaching 400 Daily Orders Across the UAE

Indeterminate EIN Presswire

14 hours ago

Mint Ops becomes an official reseller of the Coro cybersecurity platform, bringing single-platform security to Canadian dental practices

Indeterminate GlobeNewswire

14 hours ago

Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours

Indeterminate GlobeNewswire

14 hours ago

Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency

Indeterminate GlobeNewswire

14 hours ago

Olivaro Drops Publishes 2026 Supplement Facts and Serving Information for Its Liquid Dietary Supplement

Indeterminate GlobeNewswire

14 hours ago

Rancho Bernardo Dentistry Releases Patient Guide Comparing Professional Teeth Whitening and At-Home Kits

Indeterminate GlobeNewswire

15 hours ago

Coroner Finds Multiple Psychiatric Drugs in Mother-Daughter Murder-Suicide; Citizens Commission on Human Rights International Calls for Violence Cases to Undergo Same Tests

Indeterminate GlobeNewswire

15 hours ago

Azurity Pharmaceuticals Receives FDA Approval for Lamlique™ (lamotrigine) oral suspension

Indeterminate GlobeNewswire

15 hours ago

Nyxoah Appoints Liam Kelly as Chief Executive Officer

Indeterminate GlobeNewswire

15 hours ago

Nyxoah Nomme Liam Kelly au Poste de Chief Executive Officer

Indeterminate GlobeNewswire

15 hours ago

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

Indeterminate GlobeNewswire

15 hours ago

Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

16 hours ago

MedLegalPsych Launches Independent Psychiatric Assessment and IME Services in Winnipeg for Insurers, Employers, and Disability Case Managers

Indeterminate GlobeNewswire

16 hours ago

SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis

Indeterminate GlobeNewswire

16 hours ago

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026

Indeterminate GlobeNewswire

16 hours ago

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Indeterminate GlobeNewswire

17 hours ago

Interra Health Named Quarterfinalist in the 2026 Digital Health & AI Awards

Indeterminate GlobeNewswire

17 hours ago

ProText Mobility Issues Significant Inter-Quarter Shareholder Update: ABSA Confirms Inaugural Digital-Asset Custody Pilot as TXTM Advances Global RWA and Uplist Strategy

Indeterminate GlobeNewswire